COVID won't evolve to become 'less deadly' — and RedHill is prepping for the long haul

RedHill Biopharma’s chief operating officer, Guy Goldberg, says the company’s oral COVID-19 therapy could still be needed on a global scale.

By Kim Ribbink • July 12, 2022

Behind the new topical treatment set to disrupt the psoriasis market

Phil Brown, Dermavant’s chief medical officer, discusses VTAMA — the first topical cream approved for psoriasis in 25 years.

By Kelly Bilodeau • July 11, 2022

The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing

Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

By Meagan Parrish • July 7, 2022

Woman of the Week: CinCor Pharma's Terry Coelho

From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

By Taren Grom • July 6, 2022

Pharma companies take a fresh approach to inclusion in new DTC ads

AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.

By Karissa Waddick • July 5, 2022

Woman of the Week: Novartis' Marie-France Tschudin

How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

By Taren Grom • June 29, 2022

With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points

The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

By Karissa Waddick • June 28, 2022

A myriad of blows: Who's getting hit the hardest by the economy's troubles

The downturn shows few signs of hurting large pharma, but small biotechs and generics makers could face a credit crunch.

By Kim Ribbink • June 27, 2022

TikTok tutorial: How pharma can embrace the video platform's educational potential

Ogilvy Health’s director of social strategy, Katie Ferrigno, busts myths and provides tips on how biopharmas can take advantage of TikTok’s unique features to connect with patients.

By Karissa Waddick • June 15, 2022

Aduhelm's Medicare woes leave questions about lofty premiums

A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.

By Kelly Bilodeau • June 2, 2022

Flagship's creative approach to finding the next big idea in biopharma

Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

By Alexandra Pecci • June 1, 2022

PBMs under fire for drug prices defend their worth

A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.

By Michael Gibney • May 26, 2022

A potential COVID-19 EUA could turn this small biotech into a household name

Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

By Meagan Parrish • May 19, 2022

Ironwood Pharmaceuticals is charting a course to become a giant in GI

Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market. 

By Karissa Waddick • May 19, 2022

It's time to acknowledge access as a prescribing barrier

A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

By Karissa Waddick • May 11, 2022

Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

By Taren Grom • May 9, 2022

Right-sizing the channel strategy for maximum impact

Failure to right-size your distribution model imposes financial penalties and wasted expenditures.

May 9, 2022

Pharma's solution to the digital advertising dilemma? Storytelling

Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

By Karissa Waddick • May 5, 2022

From the fringes to the forefront — the mRNA era has taken hold of pharma

A look at what’s next for the industry’s buzziest technology.

By Kim Ribbink • April 22, 2022

For Global Blood Therapeutics, the connection to sickle cell disease runs deep

An underserved patient population is a guiding light for the company, which recently scored a new approval.

By Robin Robinson • April 19, 2022

How pharma can up its social media game

Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities. 

By Karissa Waddick • April 18, 2022

How Congress could play a role in personalized medicine

PGx — a tool to help determine proper dosing — may be poised to achieve broader use in healthcare and pharma.

By Kelly Bilodeau • April 11, 2022

Optinose CEO senses big opportunities for the company's nasal delivery device

Peter Miller explains how a repackaged sinus drug has won late-stage clinical success.

By Jared Whitlock • April 11, 2022

Time-saving tech lights Alcon's path into digital innovation

Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a  North Star when developing digital tools.

By Kim Ribbink • April 4, 2022

Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson

The CEO is setting a path to transform women’s health at an opportune time.

By Taren Grom • March 30, 2022